Abstract
Introduction
Humans are continuously exposed to both natural and man-made sources of ionizing radiation (IR) in their daily life, which include natural background, occupational, medical and radio-therapeutic doses of radiation. It is widely accepted that IR at high doses is detrimental to human health. However, the effect of low and moderate doses of IR is inconsistent and inconclusive. In recent years, a number of epidemiological studies are conducted in human population to delineate the effect of low doses of IR (1) (2) (3) . At the same time, efforts have been made worldwide to generate radiobiological data on in human cells, tissues and organisms exposed to IR. In addition, it is also important to understand the biological mechanisms occurring in human cells exposed to low to moderate doses of IR. The Linear No Threshold (LNT) hypothesis is well debated as the data for low-dose exposures were extrapolated from high acute-dose exposures. The mechanism of carcinogenesis at low-dose radiation exposures is not yet clearly understood. Hence, it is essential to conduct dose response and radio adaptive response (RAR) studies in human cells to understand the biological mechanisms including various pathways of DNA repair involved in the interaction of IR (4) . RAR is a phenomenon where a small dose (priming) of radiation reduces the response/effect to a subsequent larger (challenging) dose (5) (6) (7) (8) . It is assumed that RAR may be either due to enhanced repair of DNA damage or protection against the adverse effects induced by high challenging doses (9) . Thus it is important to understand the repair of DNA damages produced by IR at low to moderate doses of exposure in human cells ex vivo. Low linear energy transfer (LET) radiation such as gamma radiation deposits ~70% of the energy that induces isolated lesions, which add to the oxidative burden of the cell (10) . IR induces isolated DNA lesions, DNA protein cross links and clustered DNA damages that include bi-stranded clusters such as double-strand breaks (DSBs) or non-DSB-clustered damage. In mammalian cells, gamma radiation induces around 850 pyrimidine lesions, 450 purine lesions, 1000 single strand breaks (SSBs) and DSBs/cell/Gy (10) (11) . However, the efficient DNA repair machinery in human constantly repairs various DNA lesions through biochemical and molecular pathways to maintain the genome integrity (12) . If the damages are unrepaired or mis-repaired, it may lead to alteration in transcription and protein expression profile and activation of cell cycle check points. It may also lead to cell death (apoptosis) and mutagenesis (13) (14) (15) .
A typical therapeutic dose of around 2.0 Gy/fraction of gamma radiation produces ~3000 DNA lesions per cell exposed, a level of damage far lower than the level of up to 50000 lesions produced daily through reactive oxygen species (ROS). It is known that DNA DSBs are highly deleterious and at the same time, the cytotoxic and mutagenic nature of SSBs, oxidised bases and abasic sites cannot be underestimated as they have been associated with many cancers, neurodegenerative disorders and age-related diseases (16) (17) . BER pathway plays an important role in the removal of these damages, which are formed either spontaneously or by chemical reactions or ROS generation. It maintains the genomic integrity and prevents mutations associated with a common product of oxidative damage to DNA (18) (19) 
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BER pathway involves various steps for damage removal, which includes excising the damaged moiety, incision of the abasic site, replacing the excised nucleotide and sealing the nicks as shown in figure 1.
It is initiated by DNA glycosylases that are either mono-functional or bi-functional in nature based on their catalytic mechanism and ability to execute AP lyase strand cleavage activity (20) (21) NEIL1) exhibit base excision activity and harbour the capacity to incise at the abasic site to create a SSB (22) (23) . AP sites are further processed by APE1 (24) (25) . BER is operated through two different sub-pathways (short and long patch) depending on the type of damage. The genes involved in short-patch BER pathway are XRCC1 (X-ray cross-complementing factor 1) and DNA LIGASE3, whereas in long-patch BER pathway, PCNA (proliferating cell nuclear antigen), FEN1 (Flap endonuclease 1) and DNA LIGASE 1 are involved (26) (27) . In addition, there are other factors such as poly (ADP-ribose) polymerase 1 (PARP1) that is known to repair single-strand DNA nicks and even involved in recruiting other BER proteins onto the damaged site (28).
However, the determining factor for the activation of both the sub-pathways is not known yet. It is also not clear whether both the sub-pathways work simultaneously or in an independent manner.There is sufficient evidence that the effect of radiation is qualitatively and quantitatively different at low to moderate doses as compared to highdose exposures. The dose, dose rate and time period between priming and challenging dose are crucial for a cell to induce RAR. Besides these factors, humans also display a high degree of inter-individual variation that may play an important role in radioadaptive response as it is dependent on the radio-sensitivity of an individual. Considering all these factors, induction of repair processes and protection of radiationinduced damage by the RAR in human cells are very complex.
RAR have been demonstrated in vitro and in vivo using various end points such as cellular damage, cell lethality, chromosomal aberrations, mutation induction, radiosensitivity and DNA repair. (30) (31) (32) . Our group has demonstrated active involvement of NHEJ and BER genes and proteins in repairing radiation-induced damage in G0/G1 stage of human peripheral blood mononuclear cells (PBMC) up to 4 h (30, (33) (34) . RAR has been demonstrated when both the conditioning and challenge doses are applied at late stages (S/G2 phases) of the cell cycle. Human PBMC are in the resting stage (G0/G1) of the cell cycle and are considered to be highly sensitive and thus an ideal choice to study ex vivo exposure. In the present study, an attempt has been made to find out the involvement, if any, of BER genes and proteins in RAR, in resting human PBMC exposed to gamma radiation.
Materials and methods

Sample collection and Irradiation
Venus blood samples were collected from twenty random, normal and healthy individuals (Age range: 25 to 40 years) in EDTA containing vacutainers with written
FOUNDER'S DAY SPECIAL ISSUE 2015 FOUNDER'S DAY SPECIAL ISSUE 2015 FOUNDER'S DAY SPECIAL ISSUE 2015 FOUNDER'S DAY SPECIAL ISSUE 2015
informed consent which was approved by Medical ethic committee, BARC, Mumbai. All the individuals included in this study are non-smokers and having no chronic illness. Approximately, 12.0 ml of venous blood was collected from each individual, PBMCs were isolated through density gradient centrifugation and divided into different aliquots (~ 1 X 10 6 cells/ml) for further experiments. PBMCs were re-suspended in RPMI-1640 medium (Hi-Media Pvt. Ltd., Mumbai) containing 10% fetal bovine serum (FBS), 2.0 mM L-glutamine and mixture of antibiotics. These were exposed to different doses of gamma irradiation (0.1, 0.3, 0.6, 1.0 and 2.0 Gy) using 60 CO source (Bhabhatron II, Panacea Medical Technologies, Banglore, India).
Dose response study
PBMCs were irradiated at different doses of radiation between 0.1 to 2.0 Gy. DNA damage was quantified immediately after irradiation. For gene expression analysis, one set was processed immediately after irradiation (0 h) and the other set was processed after 4 h of incubation at 37°C.
Repair kinetics or post irradiation experiments
PBMCs were irradiated at 1.0 Gy and 2.0 Gy and incubated at different time intervals up to 240 min. Aliquots of PBMCs were collected at various time intervals of post irradiation for gene and protein expression studies.
Radio-adaptive response study
PBMCs were irradiated at a priming dose of 0.1 Gy followed by a challenging dose of 2.0 Gy after an incubation of 4 h at 37°C (primed cells). Along with this, aliquots for priming dose and challenging dose alone (non-primed cells) were also collected. Unirradiated PBMCs were simultaneously processed as a control along with the irradiated samples for all the above experiments.
DNA damage measurement using comet assay
DNA damage and its repair kinetics were studied in irradiated PBMCs using alkaline single cell gel electrophoresis (comet assay) as per the protocols described by Singh et al., 1998 (35) . SYBR Green I stained slides in duplicates were analysed in fluorescent microscope. About 100 cells (50 cells from each slide) were randomly selected and quantified with the TriTek Comet Score FreeWare TM version 1.5 and DNA damage in terms of percentage of DNA in tail (%T) was calculated.
Gene expression analysis
Total RNA was extracted from irradiated PBMCs and was reverse transcribed to cDNA. Analysis of gene expression pattern of the BER genes [short patch (OGG1, NTH1, NEIL1, XRCC1, and LIGASE3), regulatory (APE1, PARP1) and long patch (MUTYH, MBD4, PCNA, FEN1 and polymerase chain reaction the specific amplified product of interest.
Protein expression analysis BER protein expression was studied using Western blot. Nuclear extracts were obtained from control and irradiated PBMCs carried out using 100µg of protein per sample on SDS specific antibodies. β-actin was used as a loading control.
Statistical analysis
The level of significance was set at p analysis was performed in order to see the correlation between irradiated and control samples for DNA damage. difference between irradiated and un expression and protein expression analysis.
Results
DNA damage, repair kinetics, gene and protein expression profile were studied in gamma irradiated PBMCs of twenty individuals at different doses up to 2.0 Gy. In addition, adaptive response study was done in PBMCs of these individuals with a priming dose of 0.1 Gy followed by a challenging dose of 2.0 Dose response study at the level of DNA damage, transc expression Quantitation of DNA damage in terms of percentage of DNA in tail (%T) was done using alkaline comet assay at various doses (0.1, 0.3, 0.6, 1.0, 2.0 Gy) of gamma radiation along with un-irradiated control Protein expression analysis BER protein expression was studied using Western blot. Nuclear extracts were obtained from control and irradiated PBMCs at 30 min post irradiation. Electrophoresis was carried out using 100µg of protein per sample on SDS-polyacrylamide gels using actin was used as a loading control.
The level of significance was set at p≤0.05 for all statistical analysis. analysis was performed in order to see the correlation between irradiated and control samples for DNA damage. Paired 't' test was performed to find out the significan difference between irradiated and un-irradiated samples for DNA damage, gene expression and protein expression analysis.
DNA damage, repair kinetics, gene and protein expression profile were studied in gamma irradiated PBMCs of twenty individuals at different doses up to 2.0 Gy. In addition, adaptive response study was done in PBMCs of these individuals with a priming dose of 0.1 Gy followed by a challenging dose of 2.0 Gy with incubation of 4h. )] was carried out using real time quantitative-PCR). Melting curve analysis was also done to ensure BER protein expression was studied using Western blot. Nuclear extracts were obtained . Electrophoresis was polyacrylamide gels using all statistical analysis. Regression analysis was performed in order to see the correlation between irradiated and control 't' test was performed to find out the significant irradiated samples for DNA damage, gene DNA damage, repair kinetics, gene and protein expression profile were studied in gamma irradiated PBMCs of twenty individuals at different doses up to 2.0 Gy. In addition, adaptive response study was done in PBMCs of these individuals with a Gy with incubation of 4h. showed a significant increase (p<0.05) in expression at lower doses up to 0.6 Gy. PARP1 showed significant increase in expression at 4 h post irradiation at 1.0 Gy. MBD4 showed significant dose dependent increase in expression whereas LIGASE1 showed a significant increase in expression after 0.6 Gy at 4 h post irradiation.
Dose response study of BER proteins in PBMCs exposed to various doses between 0.1 Gy to 2.0 Gy showed short patch BER proteins such as XRCC1, OGG1 and LIGASE3 were significantly up regulated upto 0.6 Gy (figure 4). APE1 showed dose dependent increase in protein expression, whereas PARP1 showed increased expression at 0.6 Gy (1.4 fold) and 1.0 Gy (1.8 fold) as compared to control. Similarly, long patch BER proteins such as MUTYH showed no change in protein expression as compared to control, whereas MBD4 showed ~ 2.7 fold increased expression up to 2.0 Gy. PCNA showed a marginal change in protein expression whereas FEN1 protein was up regulated from 0.3 Gy to 2.0 Gy (ranging from 1.5 to 2.1 fold). LIGASE1 showed dose dependent increase in protein expression with a maximum of ~2.0 fold increase at 2.0 Gy as compared to control. Protein expression profile was studied for BER proteins at 1.0 Gy and 2.0 Gy with various time intervals up to 240 min. At 1.0 Gy, OGG1 showed an increase in protein expression upto 60 min. XRCC1 showed increased expression only at 240 min for 1.0 Gy and 2.0 Gy (~2.7 fold). At 1.0 Gy, LIGASE3 showed no change in protein expression, while increase in expression upto 240 min was observed at 2.0 Gy (2.0 to 2.5 fold). APE1 showed increased expression with time (2.3 to 3.0 fold at 1.0 Gy and 2.0 Gy), whereas PARP1 showed an increase in protein expression upto 60 min at 1.0 Gy and 2.0 Gy. However, MUTYH showed no change in expression both at 1.0 and 2.0 Gy. At 1.0 Gy, MBD4 and LIGASE1 showed an increased expression upto 60 min, whereas PCNA and FEN1 showed increased protein expression at 120 min and 240 min. At 2.0 Gy, MBD4, PCNA and FEN1 showed no change in expression, whereas LIGASE1 showed an increase in expression upto 240 min.
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Radio-adaptive response study at the level of DNA damage, transcript and protein expression
Adaptive response study was carried out in PBMCs of twenty individuals and end points such as DNA damage, gene and protein expression were studied. DNA damage quantitation in terms of DNA damage in tail (%T) was carried out in PBMCs exposed to a priming dose of 0.1 Gy followed by challenging dose of 2.0 Gy after 4h ( Figure 5 ).
A significant reduction (p≤0.05) was observed in % T among the individuals studied. The mean %T was 11.07 % at 2.0 Gy, which was reduced to 9.42 % in samples receiving a priming dose of 0.1 Gy followed by a challenging dose of 2.0 Gy after 4 h. Further stratification of samples into two groups revealed that twelve individuals (Group I) were showing a significant reduction (p ≤ 0.05) in the mean %T. Among these individuals the mean %T was 10.78 % at 2.0 Gy, which was reduced to 8.39 % in primed cells. However, eight individuals (Group II) showed marginal reduction in mean %T. Among these individuals, the mean %T was 11.49 % at 2.0 Gy, which was reduced to to 10.97 % in primed cells.
The relative expression of twelve BER genes was also studied in both the groups (Group I and Group II) as shown in figure 6 . Group I individuals revealed that OGG1, XRCC1, LIGASE3, APE1, FEN1 and LIGASE1 showed a significant increase in expression in primed cells as compared to 0.1 Gy or 2.0 Gy (non-primed) alone. IR induced DNA Damage Response (DDR) also lead to alteration of gene expression profile in human cells (34, 36) . Our results showed dose and time dependent transcriptional changes of BER genes such as MBD4, LIGASE1 and LIGASE3. MBD4 is involved in DNA demethylation, wherein the degree of differential methylation varies with radiation dose and time. Significant up regulation of MBD4 at the level of transcription and protein expression with radiation dose and time points studied is supportive of the above facts. Similarly, significant up regulation of LIGASE1 (long patch BER) and LIGASE3 (short patch BER) with respect to dose and time points studied indicated both short and long patch BER pathways are active in resting PBMCs exposed to gamma radiation.
PCNA and MUTYH did not show any change in expression at transcript and protein level across all the doses studied. However, regulatory BER proteins such as APE1 and PARP1 showed significantly increased expression profile up to 4 h indicating their role in activating SSBs repair and recognition of BER components. Interestingly, we have observed that short patch BER proteins such OGG1, XRCC1 and LIGASE3 showed significant up regulation at lower doses up to 0.6 Gy, while long patch BER proteins such as MBD4, FEN1 and LIGASE1 were significantly up regulated at higher doses studied (≥ 1.0 Gy). The possible explanation could be lower induction of DNA damage favours short patch BER pathway to be more active as complex lesions are comparatively less at low doses exposures ≤ 0.6 Gy. At the same time, increased expression of long patch BER protein at doses ≥1.0 Gy, perhaps indicating that lesions are more complex thus activating induction of increased fold of expression of long patch BER proteins.
Adaptive response study was carried out in resting human PBMCs exposed to gamma radiation at a priming dose of 0.1 Gy followed by challenging dose of 2.0 Gy at 4h post irradiation and different endpoints such as DNA damage, the expression of BER genes and proteins were studied. Interestingly, variation in DNA damage among the twenty individuals was observed. Individuals belonging to Group I (N=12) showed significant reduction of DNA damage (%T) whereas individuals belonging to Group II (N=8) showed marginal reduction in DNA damage (%T) though not significant. At transcript level, Group I individuals showed significant up regulation of short patch BER genes (XRCC1 and LIGASE3) in primed cells, whereas no significant change was observed in Group II individuals. This is a major difference between Group I and Group II individuals at transcript level. At transcript level, long patch BER genes have not shown distinct differences between the two groups. At protein level, short patch BER proteins (OGG1, XRCC1 and LIGASE3) and regulatory protein (APE1) showed significantly increased protein expression in primed cells of Group I individuals. Among Group II individuals, only APE1 showed increased protein expression profile.Another interesting observation at protein level is that short patch repair proteins showing significant adaptive response among Group I individuals. At the same time, Group II individuals showed increased expression of most of the long patch repair proteins including LIGASE1, suggesting the role of long patch repair proteins in RAR observed in Group II individuals.
Conclusion
In conclusion, the present study demonstrated active role of BER genes and proteins in radio-adaptive response in human PBMCs at G 0 /G 1 . The dose at which short-patch and long-patch repair pathway gets activated is an important finding in this study which needs to be further investigated in cellular extracts and stimulated lymphocytes. It would be very interesting to extend further research with chronic doses of radiation. The extent of RAR in humans not only depends on dose or dose rate but even on the heterogeneity among the individuals exhibiting this response, which remains still unresolved. A deeper understanding of the radio-adaptive response and the interplay of all the repair pathways such as BER, NHEJ and NER is needed before estimating risk of low dose of IR for humans.
